298 related articles for article (PubMed ID: 31570381)
1. Tumor-Based Genetic Testing and Familial Cancer Risk.
Forman A; Sotelo J
Cold Spring Harb Perspect Med; 2020 Aug; 10(8):. PubMed ID: 31570381
[TBL] [Abstract][Full Text] [Related]
2. Toward Concurrent Testing for Somatic and Germline Variants in Cancer Patients.
Mandelker D
Clin Cancer Res; 2016 Aug; 22(16):3987-8. PubMed ID: 27307597
[TBL] [Abstract][Full Text] [Related]
3. When Should Tumor Genomic Profiling Prompt Consideration of Germline Testing?
DeLeonardis K; Hogan L; Cannistra SA; Rangachari D; Tung N
J Oncol Pract; 2019 Sep; 15(9):465-473. PubMed ID: 31509718
[TBL] [Abstract][Full Text] [Related]
4. The role of genomic profiling in adolescents and young adults (AYAs) with advanced cancer participating in phase I clinical trials.
McVeigh TP; Sundar R; Diamantis N; Kaye SB; Banerji U; Lopez JS; de Bono J; van der Graaf WTA; George AJ
Eur J Cancer; 2018 May; 95():20-29. PubMed ID: 29614442
[TBL] [Abstract][Full Text] [Related]
5. Use of Treatment-Focused Tumor Sequencing to Screen for Germline Cancer Predisposition.
Lau TTY; May CM; Sefid Dashti ZJ; Swanson L; Starks ER; Parker JDK; Moore RA; Tucker T; Bosdet I; Young SS; Santos JL; Compton K; Heidary N; Hoang L; Schrader KA; Sun S; Kwon JS; Tinker AV; Karsan A
J Mol Diagn; 2021 Sep; 23(9):1145-1158. PubMed ID: 34197922
[TBL] [Abstract][Full Text] [Related]
6. Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art.
Rimini M; Presi S; Pipitone GB; Russo Raucci A; Ratti F; Della Corte A; Pedica F; Vanella G; Tonon G; Burgio V; Vitiello F; Rossari F; Amadeo E; Maria Giulia C; Pecciarini L; Arcidiacono PG; Falcinelli F; Cascinu S; De Cobelli F; Aldrighetti L; Patricelli MG; Carrera P; Casadei-Gardini A
Expert Rev Gastroenterol Hepatol; 2024; 18(4-5):141-146. PubMed ID: 38584510
[TBL] [Abstract][Full Text] [Related]
7. Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics.
Koster R; Schipper LJ; Giesbertz NAA; van Beek D; Mendeville M; Samsom KG; Rosenberg EH; Hogervorst FBL; Roepman P; Boelens MC; Bosch LJW; van den Berg JG; Meijer GA; Voest EE; Cuppen E; Ruijs MWG; van Wezel T; van der Kolk L; Monkhorst K
Genet Med; 2024 Feb; 26(2):101032. PubMed ID: 38006283
[TBL] [Abstract][Full Text] [Related]
8. Multidisciplinary interventions in a specialist Drug Development Unit to improve family history documentation and onward referral of patients with advanced cancer to cancer genetics services.
Moss CA; Cojocaru E; Hanwell J; Ward S; Xu W; van Zyl M; O'Leary L; de Bono JS; Banerji U; Kaye SB; Minchom A; George AJ; Lopez J; McVeigh TP
Eur J Cancer; 2019 Jun; 114():97-106. PubMed ID: 31078974
[TBL] [Abstract][Full Text] [Related]
9. Genetic Testing Utilization: Discrepancies Between Somatic and Germline Results in Patients With Cancer Reviewed at the UW Health Precision Medicine Molecular Tumor Board.
Horn IP; Zakas AL; Smith-Simmer KJ; Birkeland LE; Sundstrom R; Burkard ME; Weiss JM
JCO Precis Oncol; 2024 May; 8():e2300466. PubMed ID: 38810171
[TBL] [Abstract][Full Text] [Related]
10. The Future of Parallel Tumor and Germline Genetic Testing: Is There a Role for All Patients With Cancer?
Liu YL; Stadler ZK
J Natl Compr Canc Netw; 2021 Jul; 19(7):871-878. PubMed ID: 34340209
[TBL] [Abstract][Full Text] [Related]
11. Cascade testing for hereditary cancer: comprehensive multigene panels identify unexpected actionable findings in relatives.
Heald B; Pirzadeh-Miller S; Ellsworth RE; Nielsen SM; Russell EM; Beitsch P; Esplin ED; Nussbaum RL; Pineda-Alvarez DE; Kurian AW; Hampel H
J Natl Cancer Inst; 2024 Feb; 116(2):334-337. PubMed ID: 37756683
[TBL] [Abstract][Full Text] [Related]
12. "Somatic" Tumor Genomic Profiling and Potential Germline Implications: Ethical Considerations for Children with Cancer.
Knapp E
J Law Med Ethics; 2020 Dec; 48(4):778-783. PubMed ID: 33404327
[No Abstract] [Full Text] [Related]
13. Clinical Multigene Testing for Prostate Cancer.
Berro T; Barrett E; AlDubayan SH
Urol Clin North Am; 2021 Aug; 48(3):297-309. PubMed ID: 34210486
[TBL] [Abstract][Full Text] [Related]
14. Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma.
Walker EJ; Carnevale J; Pedley C; Blanco A; Chan S; Collisson EA; Tempero MA; Ko AH
Fam Cancer; 2019 Apr; 18(2):241-251. PubMed ID: 30267352
[TBL] [Abstract][Full Text] [Related]
15. Tumor-only sequencing for oncology management: Germline-focused analysis and implications.
George A; Turnbull C
Genes Chromosomes Cancer; 2021 May; 60(5):352-357. PubMed ID: 33222309
[TBL] [Abstract][Full Text] [Related]
16. Germline Genetic Testing: What the Breast Surgeon Needs to Know.
Plichta JK; Sebastian ML; Smith LA; Menendez CS; Johnson AT; Bays SM; Euhus DM; Clifford EJ; Jalali M; Kurtzman SH; Taylor WA; Hughes KS
Ann Surg Oncol; 2019 Jul; 26(7):2184-2190. PubMed ID: 30941656
[TBL] [Abstract][Full Text] [Related]
17. Germline Testing for the Evaluation of Hereditary Cancer Predisposition.
Ceyhan-Birsoy O
Clin Lab Med; 2022 Sep; 42(3):497-506. PubMed ID: 36150826
[TBL] [Abstract][Full Text] [Related]
18. Germline and Somatic Tumor Testing in Gynecologic Cancer Care.
Alldredge J; Randall L
Obstet Gynecol Clin North Am; 2019 Mar; 46(1):37-53. PubMed ID: 30683265
[TBL] [Abstract][Full Text] [Related]
19. Tumor Genomic Testing: Identifying Characteristics Associated With Germline Risk for Developing Malignancy.
Mahon SM
Clin J Oncol Nurs; 2020 Dec; 24(6):623-626. PubMed ID: 33216058
[TBL] [Abstract][Full Text] [Related]
20. Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings.
Seifert BA; O'Daniel JM; Amin K; Marchuk DS; Patel NM; Parker JS; Hoyle AP; Mose LE; Marron A; Hayward MC; Bizon C; Wilhelmsen KC; Evans JP; Earp HS; Sharpless NE; Hayes DN; Berg JS
Clin Cancer Res; 2016 Aug; 22(16):4087-4094. PubMed ID: 27083775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
